Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 16 May | 4.16 |
0 (0.00%) |
OPEN
4.15 |
HIGH
4.16 |
LOW
4.15 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
| OPEN | 4.15 |
| PREVIOUS CLOSE | 4.16 |
| VOLUME | 320 |
| 52-Week high | 9.55 |
| 52-Week low | 3.67 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bacil Pharma Ltd. (BACILPHARMA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 891.90 | 0.69 | 966.90 | 652.75 | 213993.56 |
| Divi's Lab. | 4278.40 | 1.39 | 5425.00 | 3790.00 | 113570.13 |
| Cipla | 925.70 | -0.79 | 1083.15 | 850.00 | 74685.48 |
| Dr Reddy's Labs | 3891.00 | 0.10 | 5613.65 | 3655.00 | 64754.02 |
| Apollo Hospitals | 3825.00 | 3.71 | 5930.70 | 3114.45 | 54995.85 |
| Gland Pharma | 3157.90 | 1.55 | 4350.00 | 2767.65 | 51979.03 |
| Piramal Enterp. | 1961.90 | 4.63 | 3013.00 | 1625.00 | 46820.74 |
| Torrent Pharma. | 2583.20 | -0.05 | 3304.45 | 2485.00 | 43712.91 |
| Biocon | 329.15 | 2.89 | 420.25 | 314.90 | 39517.75 |
| Zydus Lifesci. | 347.55 | 0.70 | 668.85 | 319.40 | 35578.69 |
| Max Healthcare | 366.80 | -0.31 | 472.60 | 205.00 | 35566.03 |
| Abbott India | 16600.00 | 0.43 | 23902.30 | 15525.00 | 35275.00 |
| Alkem Lab | 2895.00 | -0.24 | 4067.70 | 2835.00 | 34609.72 |
| Aurobindo Pharma | 538.00 | -2.32 | 1043.00 | 536.40 | 31521.42 |
| Lupin | 687.10 | 0.36 | 1267.50 | 672.80 | 31228.70 |
| Laurus Labs | 554.55 | 2.26 | 723.55 | 433.20 | 29798.74 |
| Glaxosmi. Pharma | 1513.05 | -0.07 | 1917.00 | 1433.05 | 25632.58 |
| Ipca Labs. | 990.00 | 0.62 | 1383.55 | 917.00 | 25116.30 |
| Syngene Intl. | 551.65 | 3.39 | 699.95 | 508.10 | 22144.89 |
| Pfizer | 4255.45 | 1.13 | 6164.80 | 4077.80 | 19468.68 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
